Results
|
61.
|
|
|
62.
|
|
|
63.
|
|
|
64.
|
|
|
65.
|
|
|
66.
|
|
|
67.
|
The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group. [electronic resource] by
- Gisolf, E H
- Jurriaans, S
- Pelgrom, J
- van Wanzeele, F
- van der Ende, M E
- Brinkman, K
- Borst, M J
- de Wolf, F
- Japour, A J
- Danner, S A
Producer: 20000621
In:
AIDS (London, England) vol. 14
Availability: No items available.
|
|
68.
|
|
|
69.
|
Alanine glyoxylate aminotransferase and the urinary excretion of oxalate and glycollate in hyperoxaluria type I and the Zellweger syndrome. [electronic resource] by
- Wanders, R J
- van Roermund, C W
- Westra, R
- Schutgens, R B
- van der Ende, M A
- Tager, J M
- Monnens, L A
- Baadenhuysen, H
- Govaerts, L
- Przyrembel, H
Producer: 19871027
In:
Clinica chimica acta; international journal of clinical chemistry vol. 165
Availability: No items available.
|
|
70.
|
|
|
71.
|
|
|
72.
|
|
|
73.
|
A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team. [electronic resource] by
- Haubrich, R
- Thompson, M
- Schooley, R
- Lang, W
- Stein, A
- Sereni, D
- van der Ende, M E
- Antunes, F
- Richman, D
- Pagano, G
- Kahl, L
- Fetter, A
- Brown, D J
- Clumeck, N
Producer: 20000124
In:
AIDS (London, England) vol. 13
Availability: No items available.
|
|
74.
|
|
|
75.
|
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection. [electronic resource] by
- Frissen, P H
- van der Ende, M E
- ten Napel, C H
- Weigel, H M
- Schreij, G S
- Kauffmann, R H
- Koopmans, P P
- Hoepelman, A I
- de Boer, J B
- Weverling, G J
Producer: 19940630
In:
The Journal of infectious diseases vol. 169
Availability: No items available.
|
|
76.
|
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience. [electronic resource] by
- Schooley, R T
- Clumeck, N
- Haubrich, R
- Thompson, M
- Danner, S A
- van Der Ende, M E
- Sereni, D
- Antunes, F
- Blake, D
- Myers, R E
- Tisdale, M
- Millard, J
- Mustafa, N
- Nacci, P
Producer: 20020114
In:
Antiviral therapy vol. 6
Availability: No items available.
|
|
77.
|
|
|
78.
|
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy. [electronic resource] by
- van Leth, F
- Wit, F W N M
- Reiss, P
- Schattenkerk, J K M E
- van der Ende, M E
- Schneider, M M E
- Mulder, J W
- Frissen, P H J
- de Wolf, F
- Lange, J M A
Producer: 20040604
In:
HIV medicine vol. 5
Availability: No items available.
|
|
79.
|
The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors. [electronic resource] by
- van der Ende, M Yldau
- Hartman, Minke H T
- Hagemeijer, Yanick
- Meems, Laura M G
- de Vries, Hendrik Sierd
- Stolk, Ronald P
- de Boer, Rudolf A
- Sijtsma, Anna
- van der Meer, Peter
- Rienstra, Michiel
- van der Harst, Pim
Producer: 20171109
In:
International journal of cardiology vol. 228
Availability: No items available.
|
|
80.
|
Favourable SVR12 rates with boceprevir or telaprevir triple therapy in HIV/HCV coinfected patients. [electronic resource] by
- Arends, J E
- van der Meer, J T M
- Posthouwer, D
- Kortmann, W
- Brinkman, K
- van Assen, S
- Smit, C
- van der Valk, M
- van der Ende, M
- Schinkel, J
- Reiss, P
- Richter, C
- Hoepelman, A I M
Producer: 20161213
In:
The Netherlands journal of medicine vol. 73
Availability: No items available.
|